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Abstract.  Rat cerebral  astroglial cells in culture dis- 
play specific morphological and biochemical behaviors 
in response to exogenously added gangliosides. To ex- 
amine a potential function for endogenous gangliosides 
in the processes of astroglial cell differentiation, we 
have used the B  subunit of cholera toxin as a  ganglio- 
side-specific probe.  The B  subunit, which is multiva- 
lent and binds specifically to GM1  ganglioside on the 
cell surface, induced a  classical star-shaped (stellate) 
morphology in the astroglial cells and inhibited DNA 
synthesis in a  dose-dependent manner. The morpho- 
logical response was massive and complete within 2  h, 
with an EDs0 of 0.8 nM, and appeared to depend on 
the direct interaction of the B  subunit with GM1  on 
the cell surface. A  B subunit-evoked inhibition of 
DNA synthesis and cell division (EDs0  =  0.2 nM) was 
observed when the cells were stimulated with defined 
mitogens, such as epidermal growth factor and basic 
fibroblast growth factor. Maximal inhibition ap- 
proached 80%  within 24 h.  The effects of the B sub- 
unit were unrelated to increases in cAMP.  These ob- 
servations, taken together with previous studies, 
demonstrate that both endogenously occurring plasma 
membrane gangliosides and exogenously supplied gan- 
gliosides can influence the differentiative state (as 
judged by morphological and growth behaviors) of as- 
troglial cells in vitro. 
ANGLIOSIDES, sialic acid-containing glycosphingo- 
lipids (44), are normal membrane constituents, largely 
localized to the outer leaflet of the plasma membrane 
and thus presenting their carbohydrate moieties on the sur- 
face of the cells (49).  They are abundant in neural tissues, 
and the ganglioside compositions of neuronal and glial cell 
membranes appear to be different (25).  Numerous studies 
have identified effects of exogenously supplied gangliosides 
on neuronal cells, both in vitro (11, 26, 27, 38) and in vivo 
(8, 34, 39, 45). There have been, however, few investigations 
addressing possible interactions of gangliosides with glial 
cells. 
Rat astroglial cells in vitro have been reported to display 
two responses to GM1 and other gangliosides. One ganglio- 
side effect is prevention or reversal of the assumption by flat 
astroglial cells of a stellate (star shaped) morphology under 
the  influence  of certain  agents  (12, 37),  which  include 
neuron-released molecules  such as  neurotransmitters and 
neuropeptides (29).  The other ganglioside effect is that of 
growth modulation in these cells (23, 36). A possible role for 
endogenously derived gangliosides in these astroglial cell 
behaviors was never examined. 
Several studies have indicated that the cross-linking of cell 
surface gangliosides can influence some (41, 42),  but not 
other (9,  10) cellular behaviors. For example, the B subunit 
of cholera toxin, which is multivalent and binds exclusively 
to GM1  ganglioside on the cell surface (15), has been re- 
ported to induce the proliferation of lymphocytes (42) and 
growth-arrested, nontransformed 3T3 fibroblasts (41). The B 
subunit, however,  inhibited the growth of rapidly dividing 
normal 3T3 cells and vitally transformed 313 cells (41). The 
molecular basis for these opposing effects of B subunit could 
conceivably reflect differences in cell metabolic properties, 
or the amount or distribution of surface GM1 being occupied 
by B subunit, the latter suggested by Spiegel and co-workers 
(41). It has been reported that the levels of cell surface gan- 
gliosides vary as a function of 313 cell growth state (20), and 
that transformed 3T3 cells have less GM1 than normal 3T3 
cells (20). 
It is tempting to speculate that the previously observed as- 
troglial cell morphology and growth responses to exogenous 
gangliosides also depend on the amount or distribution of 
ganglioside that may be  incorporated.  At the  same time, 
nothing  is  known  concerning  the  significance  of  these 
findings with respect to the function of endogenous ganglio- 
sides in the same astroglial cellular behaviors.  Until now, 
there has been no assessment of the manipulation of endoge- 
nous ganglioside in cells displaying well-defined responses 
to the same exogenous ganglioside molecules. To investigate 
this question, we have used the B subunit of cholera toxin as 
a ganglioside-specific probe in order to examine a role for 
membrane GM1 ganglioside in the regulation of astroglial 
cell morphology and growth. The results presented here pro- 
vide the first evidence that manipulation of endogenously oc- 
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cific behaviors of astroglial cells in vitro. 
Materials and Methods 
Materials 
Eagle's  basal medium (EBM)  I and penicillin G  sodium  were  purchased 
from Gibco (Grand Island, NY); fetal calf serom from Seromed (Berlin, Fed- 
eral Republic of Germany); L-glutamine, poly-L-ornithine HBr (44,000 mol 
wt), bovine  pancreatic insulin, ovalbumin, cholera toxin, and forskolin from 
Sigma Chemical Co.  (St. Louis,  MO); bovine plasma fibronectin,  bovine 
pituitary basic fibroblast growth factor (bFGF), and mouse salivary gland 
epidermal  growth  factor  (EGF)  from  Bethesda  Research  Laboratories 
(Bethesda,  MD); B  subunit of cholera toxin from List Biological  Labs 
(Campbell, CA);  [methyl-3H]TdR (2.0 Ci/mmole) from Amersham Inter- 
national (Buckinghamshire,  England); Instagel II from Packard Instrument 
Co., Inc.  (Downers  Grove, IL). 
Cell Cultures 
Primary and secondary  cultures of astroglial  cells were  prepared from 
cerebra of l-2-d-old Sprague-Dawley rats as described previously (33). Dis- 
sociated cells were cultured in EBM modified to contain 33.3 mM D-glu- 
cose,  2  mM L-glutamine,  26.4 mM NaHCO3,  100 U/ml penicillin, and 
10% (vol/vol) heat-iuactivated FCS. These primary cultures were harvested 
10 d later in serum-free modified EBM containing 1% (vol/vol) ovalbumin 
and diluted  to 3.2  x  105 cells/ml in the modified  EBM.  The secondary 
cultures to be used experimentally  were set up by seeding 50 ttl of the final 
cell suspension into 6-mm plastic culture wells (No. 3070; Falcon Labware, 
Becton,  Dickinson &  Co.,  Oxnard,  CA)  already  containing 50  ttl  of 
medium, and which had been precoated with polyornithine and fibroneetin 
(33). Thus, each well started with 16,000 cells, •12,000  of which attached. 
All cultures received one medium change at 2 h and another at 24 h. Most 
cultures were treated and studied beginning 1 d after seeding (DI cultures) 
with the new medium containing the agent to be tested. Cultures to be used 
for morphological evaluation or cell counting were fixed with 2% (vol/vol) 
glutaraldehyde in EBM, stained with 0.1% toluidine blue, and observed un- 
der phase contrast microscopy. 
DNA Synthesis 
To evaluate DNA synthesis, cultures were pulsed at various times after pre- 
sentation  of B subunit or mitogen with 2 ttCi/ml [methyl-3H]TdR  (2 Ci/ 
mmole). After a 2-h pulse, cultures were washed twice with 1(30 ~tl of ice- 
cold PBS,  100 Ixl of cold 5 % ~  was added per well, and the cells were 
kept at 4"C for 20 rain. The TCA extract was discarded and each well 
washed three times with 100 ttl of 5% TCA.  The cells were dissolved  in 
100 ttl/well of 1 N NaOH, and the NaOH extract transferred to a scintilla- 
tion vial. Each well was washed with 100 ttl of 1 N HCI,  and this added 
to the counting vial. 5 ml of Instagel II were added to each vial, and radioac- 
tivity counted in a liquid scintillation spectrometer ('13"icarb  460 C; Packard 
Instrument Co.). 
cAMP Measurements 
Levels of intracellular cAMP were determined by mdioimmunoassay  with 
the use of protocols and kit (No. RPA 509; Amersham International) as de- 
scribed previously  for astrogiial  cells (12). The larger mounts of cellular 
material needed for cAMP analysis were prepared by seeding 1.2  x  10  5 
primary astroglial cells into 16-ram culture wells (Costar 3524; Data Pack- 
aging Corp.,  Cambridge, MA), coated with polyornithine and fibronec- 
tin (12). 
Results 
B Subunit of Cholera Toxin Induces Morphological 
Differentiation  in Astrogiial Cells 
Astroglial cells prepared from neonatal rat cerebrum and 
1. Abbreviations  used in this paper: bFGF, basic fibroblast  growth factor; 
EBM, Eagle's basal medium; EGF, epidermal growth factor. 
cultured in serum-free medium maintain a  flat, polygonal 
shape (33).  Exposure of these cells to a variety of agents 
thought to activate cAMP-synthesizing systems (e.g., cAMP 
analogues, forskolin, cholera toxin, norepinephrine, vasoac- 
five intestinal polypeptide) promotes a rapid (1-2 h) and near 
complete conversion to a process-bearing (stellate) morphol- 
ogy (12, 29, 30, 37, 48). When the astroglial cells are treated 
with ~,  O2'-dibutyryl cyclic AMP,  forskolin, or cholera 
toxin, the concurrent or delayed administration of GM1 in- 
hibits or reverses the morphological response (37).  GM1 
does not block the elevation of  cAMP that occurs in response 
to these agents (12). 
To further explore this morphological modulation of as- 
troglial  cells  by  gangliosides,  the  following  experiments 
were carried out. The B subunit of cholera toxin, which is 
pentavalent and recognizes exclusively ganglioside GM1 on 
the cell surface (15), was used as a probe to assess a role for 
endogenous gangliosides in the determination of astroglial 
cell morphology. When secondary astroglial cells at D1 were 
treated with 1 pg/ml of B subunit, a massive conversion to 
the stellate morphology occurred and was complete within 
2 h (Fig. 1). The morphology induced by B subunit is indis- 
tinguishable from that elicited by cAMP analogues (30,  37) 
or other cAMP-elevating drugs (12, 29,  48) in these cells. 
Fig. 2 illustrates the concentration dependence of the B sub- 
unit-evoked flat-to-stellate conversion in the astroglial cells. 
A maximal effect was observed at a B subunit concentration 
of 250 ng/ml (4.3 nM) or greater, with an EDs0 of 45 ng/ml 
(0.8 nM). 
Since agents that elicit cAMP elevations in astroglial cells 
also induce the stellate morphology, a trivial explanation for 
the effect of the B subunit of cholera toxin is that the prepara- 
tion used here is contaminated by the A subunit (adenylate 
cyclase activating). Several lines of evidence, however, show 
this not to be the case. In the first, the B subunit dose-re- 
sponse obtained with the commercial material was identical 
to that found using a B subunit preparation (46) kindly pro- 
vided by Dr. M. Tomasi (Laboratorio di Biologia cellulare 
e  Immunologia, Istituto Superiore di Sanifi,  Roma).  This 
latter  preparation  has  been  biologically characterized as 
devoid of any adenylate cyclase-activating A  subunit  (2). 
Secondly,  measurements  of intracellular  cAMP  levels  at 
different times failed to show any increase of cAMP after 
treatment by B subunit. As Table I illustrates, concentrations 
of the B subunit up to 20 l~g/ml were unable to stimulate 
cAMP production at any time tested. Cholera toxin at 1 lag/ 
ml, however, caused a 200-fold elevation of cAMP at 1 h in 
the astroglial cells, tapering off to about an 18-fold stimula- 
tion by 16 h. Previous studies have shown this concentration 
of cholera toxin to elicit a maximal rise of cAMP at about 
1 h in astroglial cells (12). Significant, though smaller, in- 
creases of cAMP were observed using as little as 5 ng/ml of 
cholera toxin at 1 h (data not shown). Similar results were 
obtained in independent experiments using HPLC analysis 
instead of radio-immunoassay. Thus, the B subunit used in 
our studies is devoid of any A subunit; the effects orb subunit 
on astroglial cells are unrelated to increases of cAMP. 
To confirm that the observed morphological activity was 
due to the binding of B subunit to the cells, we measured the 
ability of cholera toxin to elevate cAMP and its inhibition by 
the B subunit. The increase in cAMP at 1 h with 5 ng/ml of 
cholera toxin (59 pmol/106 cells vs. 2 pmol/106 cells for con- 
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Figure 1.  Photomicrographs of second- 
ary rat  cerebral  astroglial  cells treated 
2  h  with no agent (top) or  1 p.g/ml B 
subunit  of cholera toxin  (bottom).  Bar, 
25 ~tm. 
trol)  was inhibited by the addition of B  subunit in a  dose- 
dependent manner: 0.5 Itg/ml ofB subunit reduced the chol- 
era toxin-induced rise to 39 pmol cAMP/106 cells, while 1.5 
Itg/ml B subunit totally inhibited the effect of cholera toxin. 
Furthermore,  presentation of B subunit (20 gg/ml) 20 s be- 
Figure 2. Dose responsiveness  of  the B subunit-induced conversion 
of astroglial  cells  to the stellate  morphology. D1 cultures (16,000 
cells seeded/6  mm well) were treated  with varying concentrations 
of  the B subunit of  cholera toxin for 2 h, fixed, stained,  and the per- 
cent of steUate cells determined.  Values are averaged  from three 
replicate  experiments  (n  =  6). 
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on cAMP Levels in Astroglial Cells 
cAMP 
Addition  1 h  4 h  16 h 
pmol/lO 6 cells  pmolHO 6 cells  pmol/lO 6 cells 
None  1.9  +  0.5  1,9  +  0.6  1.9  +  0,2 
B  subunit (20 I~g/ml)  1,5  +  0.1  1.9  +  0.5  1.8  +  0.3 
Cholera toxin (1  I~g/ml)  400  +  50  142  +  46  35  +  4 
Astroglial  cells  were  seeded as secondary  cultures  (1.2  x  10  ~ per well  in 
24-well plates), and treated at DI with cholera toxin or B subunit for 1, 4, and 
16 h. The cells were then extracted with 5% TCA and cAMP measured. Each 
value is given as the mean  +  SD (n  =  6). 
fore cholera toxin (0.5 ~tg/ml) markedly reduced the cAMP 
elevation of the latter from U0 pmol/10  ~ cells to 18 pmol/106 
cells. These data make it seem likely that the effects of the 
B subunit are due to its specific binding to the cell surface 
receptor for cholera toxin, that is, GM1. Analogous results 
have been obtained in studies demonstrating a proliferative 
effect of B subunit on lymphocytes (42). 
B Subunit of  Cholera Toxin Inhibits DNA Synthesis 
and Growth of  Astroglial Cells 
Earlier findings from other laboratories have demonstrated 
that an interaction of  the B subunit with endogenous ganglio- 
sides results in stimulation or inhibition of  proliferation, de- 
pending upon the type of cell used and its growth state (41, 
42). In view of these growth regulatory effects of B subunit, 
we examined the effect of B subunit on the proliferation of 
astroglial cells. Initial experiments with D1 secondary cul- 
tures  of astroglial  cells  demonstrated  that  the  B  subunit 
caused a  dose-dependent inhibition of DNA  synthesis.  A 
concentration of ~60 ng/ml (1 nM) or greater inhibited cell 
proliferation to a maximum of 85 % at 24 h, with an EDs0 
of 12 ng/ml (0.2 nM) (Fig. 3). An identical dose-response 
curve was obtained using the B subunit of noncommercial 
origin (data not shown).  The B subunit inhibited [3H]TdR 
incorporation into the cells even when the labeling pulse was 
increased to 24 h, with B subunit continuously present (50% 
10, 
o  ....  tl  ,  ,  , 
8  16  it*  32  6~  250  1~00 
B subunit  (nglml] 
Figure 3.  Concentration dependence of B subunit inhibition of 
DNA synthesis in astroglial ceils. Cultures of secondary astroglial 
ceils at D1 (16,000  cells seeded/6 mm well) were exposed to various 
concentrations of the B subunit of cholera toxin for 24 h, and as- 
sayed for [3H]TdR incorporation into DNA during the last 2 h. 
Each value is the mean +  SD (n =  6, two experiments). 
of control). These effects of B subunit were not associated 
with loss of cell viability, nor with a reduced transport of 
[3H]TdR  into the TCA-soluble pool of the cells (data not 
shown). 
The inhibitory effect of the B subunit was also observed 
when astroglial cells were stimulated with either EGF or 
bFGF, at high or low cell densities. Table II illustrates the 
results. The B subunit (1 ~tg/ml) reduced DNA synthesis at 
24 h by 80-85 % without mitogen addition, irrespective of 
initial cell seeding density. In the presence of 10 ng/ml EGF 
(and 5  Ixg/ml insulin),  proliferation was stimulated ,.,4.5- 
fold at 24 h. Polypeptide growth factors active on astroglial 
cells generally require insulin (6, 28, 31, 36). The growth- 
stimulating effect of EGF was essentially abolished in the 
concurrent presence of 1 gg/ml B subunit, although not to 
the level seen in control cultures with the B subunit. Similar 
results were obtained with bFGF; however, this latter mito- 
gen was less effective than EGF. Insulin alone is reported to 
have no effect on DNA synthesis in cultured astroglial cells 
(6, 31, 36). 
The antiproliferative effect of the B subunit was confirmed 
by direct cell counting and autoradiography. The increase in 
cell numbers elicited by EGF or bFGF at 48 h was reduced 
in the presence of B subunit by 85 and 45 %, respectively, 
of the mitogen-stimulated values relative to control (Table 
III). In addition,  autoradiographic analysis revealed fewer 
[3H]TdR-labeled nuclei after a 24-h exposure to B subunit. 
As Table IV illustrates, the percent of labeled nuclei in cul- 
tures without mitogen decreased from 10 to 6% with B sub- 
unit, while the value of 28 % in EGF-treated cultures was re- 
duced to 10%. These results substantiate the data on direct 
cell number measurements in Table HI. The inhibitory action 
of the B subunit on astroglial cells stimulated to grow with 
EGF or bFGF most likely is not a consequence of  an interfer- 
ence by B subunit of  mitogen binding to the cells. When cells 
were first exposed to the mitogen for 24 h and then to B sub- 
unit, the same inhibition was observed. For example, 48-h 
control cultures incorporated [3H]TdR at 554 dpm/h, with 
EGF (plus insulin) yielding 2,445 dpm/h. Addition of 1 lag/ 
ml B subunit after 24 h of EGF/insutin treatment, in the con- 
tinued presence of the mitogen, decreased [3H]TdR labeling 
to 642 dpm/h 24 h later. Similar results were obtained with 
bFGE Thus, B subunit is still effective when added after a 
prior mitogen activation. 
B Subunit-evoked Inhibition of  DNA Synthesis Is a 
Time-dependent Process 
The inhibition of astroglial cell proliferation elicited by the 
B subunit of cholera toxin was also time dependent. A maxi- 
mal  inhibition of 90%  in control cells was seen at 24 h, 
whereas the B  subunit inhibited DNA  synthesis in  EGF- 
stimulated cells by 75 % at 24 h (Fig. 4). In the latter case, 
B subunit was maximally effective at 15 h (80% inhibition) 
although not significantly different from 20 and 24 h. Be- 
tween 24 and 48 h, the inhibitory effect of the B subunit be- 
gan to decrease. DNA synthesis was inhibited by 45-50% at 
48 h, and by only 25 % at 72 h in untreated cells (no inhibition 
with EGF at this time). Representation of B subunit at 72 h 
failed to initiate any additional inhibition alone or with mito- 
gen,  although the  ceils  remained responsive to  a  further 
stimulation by EGF or bFGF, again suggesting that the B 
subunit does not exert its inhibitory effects on cell prolifera- 
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[3H]TdR incorporated 
16,000 cells  4,000  cells 
Additions  -  B Subunit  +  B subunit  -  B subunit  +  B subunit 
dpm/h/well  dpm/h/well  dpm/h/well  dpm/h/well 
None  1,050  5:140  171  5:27  406  5:18  77  5:10 
EGF  5,077  5:423  1,305  =1=  220  1,670  5:248  422  5:68 
bFGF  3,448  +  435  1,557  +  325  1,187  5:185  441  5:46 
Astroglial cells were seeded as secondary cultures  in 96-well tissue culture plates in 0.l  ml EBM at 4  ￿  103 or 16  x  103 cells per well,  After  l  d, 0.1  mi of 
EBM was added containing  10 ng/mi EGF or bFGF (and 5 !ttg/ml insulin), and  1 I.tg/mi of B subunit where indicated. Incorporation of [3H]TdR was determined 
during  the last 2 h of the 24-h incubation.  Values are the mean  +  SD (n  =  8, two experiments). 
tion via an interference with growth factor binding to the 
cells. 
Discussion 
The results presented here demonstrate that the B subunit of 
cholera toxin can induce a pronounced morphological change 
and inhibit DNA synthesis in rat cerebral astroglial cells in 
vitro. This latter response to the B  subunit was also seen 
when astroglial cells not rapidly dividing were stimulated 
with defined mitogens,  such as EGF or bFGE  The only 
identified receptor for the B subunit is the ganglioside GM1 
(7, t5, 42). Studies from other laboratories have shown that 
the B  subunit is able to stimulate lymphocytes by directly 
binding to GM1 on the cell surface (42). The molecules of 
B subunit bind only to the oligosaccharide chains of  GM1 ex- 
posed on the cell surface (15, 17, 22). In this study, the ob- 
served effects of B subunit also appear to be due to the bind- 
ing of B subunit to the cells, as the ability of cholera toxin 
to stimulate cAMP levels was completely inhibited by the ad- 
dition of B  subunit.  The B  subunit, however, was equally 
effective in promoting the morphological conversion of the 
astroglial cells. 
Astroglial cells cultured in the absence of serum display 
a flat, polygonal morphology (33). Administration of cAMP 
analogues or cholera toxin (among other agents) causes the 
cells to convert to a steUate (star shaped) morphology (12, 
29, 30, 37, 48), suggesting a possible mediation through in- 
tracellular cAMP (12, 48). Treatment of these cells with the 
B subunit of cholera toxin elicited a morphological change 
that was indistinguishable from that observed with activation 
of cAMP-synthesizing systems (12, 37). The B subunit used 
here is devoid of any cAMP-elevating A subunit, in accord 
with other studies (41, 42). These results raise the possibility 
that the effects of cholera toxin on astroglial cell morphology 
may be due, at least in part, to the binding of its B subunit 
Table IlL The B Subunit of Cholera Toxin Reduces 
Mitogen-induced  Cell Number Increases 
Treatment  (48 h)  Cells/ram 2 
Control  446 +  63 
EGF  905  +  100 
EGF +  B subunit  604 -t- 90" 
bFGF  862 +  101 
bFGF +  B subunit  603  +  98" 
Secondary astroglial cells at DI (16,000 cells seeded/6 mm well) were treated 
with the indicated agents for 48 h: 1 ltg/ml B subunit:  l0 ng/ml EGF or bFGF 
(plus  5  gg/mi insulin).  Cells  were fixed, stained,  and counted under  phase 
microscopy.  Values are the mean  +  SD (n  =  8, two experiments). 
* P < 0.05 compared with mitogen without B subunit (Student's t test). 
Table IV. Autoradiographic Analysis of  the Antiproliferative 
Effect of  the B Subunit of Cholera Toxin 
Treatment  Percent labeled nuclei 
None  10  +  2 
B  subunit  6  +  1 
EGF  28  +  4 
EGF +  B subunit  10 +  3 
Secondary astroglial cell cultures at DI (I .2  x  IO  s cells seeded/t6 mm well) 
were treated for 24 h with  1 ltg/ml B subunit,  l0 nglml EGF (plus 5 Itg/ml 
insulin), or both.  Cultures were pulsed with 2 ltCi/ml  [3H]TdR for the entire 
24-h period,  and then processed for autoradiography  as described elsewhere 
(l). Each value is taken from analysis of three cultures (300~00 cells scored 
in each condition),  and is the mean  +  SD. 
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Figure 4. Time dependence of inhibition of DNA synthesis in as- 
troglial cells induced by the B subunit of cholera toxin. Cultures 
of the secondary astrog|ial cells 06,000 cells seededt6 mm well) at 
D1 were treated without and with 1 lag/rrd of B subunit, in medium 
only (o) or with the addition of EGF (10 rig/rid) and insulin (5 
I.tg/ml) (o) for various time periods. The cells were pulsed with 
[3H]TdR in the last 2 h of each period. Results are expressed as the 
percent inhibition in comparison to control cultures (no B subunit) 
for each time (mean +  SD, n  =  6). 
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nylate cyclase. Since the maintenance of the stellate mor- 
phology in astroglial cells is critically dependent on a stable 
microtubular network (5), the action of B subunit implies 
that cross-linking of surface GM1 molecules is translated to 
events at the level of the cytoskeleton. 
In this study, we also found that the B subunit can inhibit 
DNA synthesis in cultured astroglial cells that are not rapidly 
dividing. Maximal inhibition of DNA synthesis was observed 
24 h after B subunit introduction, reaching ~20 % of control 
levels.  Furthermore, the stimulation of DNA synthesis and 
cell number increases induced by EGF or bFGF was in- 
hibited to an equal extent, and was found whether the mito- 
gen was presented concurrently or 24 h before B subunit. 
The B subunit-evoked inhibition of DNA synthesis at 24 h 
was reflected in a decreased percentage of labeled nuclei at 
24 h, and a smaller increase in actual cell numbers in the 
presence of mitogen at 48 h. These anti-proliferative effects 
of  the B subunit on astroglial cells, as with the morphological 
effects,  are unrelated to increases of cAMP. 
In several other studies, the B subunit of cholera toxin has 
been reported to stimulate DNA synthesis in resting lympho- 
cytes (42)  and quiescent 313  cells (41), but to inhibit the 
growth of rapidly dividing normal 313 cells and transformed 
313 cells (41). From these observations, the above authors 
concluded that the ability of the B subunit to stimulate the 
division of resting cells is a general phenomenon, with en- 
dogenous gangliosides playing a role in the regulation of  both 
positive and negative signals for cell growth. In contrast the 
present studies demonstrate that, at least for astroglial cells 
and independent of growth state, B  subunit inhibits DNA 
synthesis. While most experiments were performed by seed- 
ing the astroglial cells directly in a  serum-free medium, 
other experiments were done in which cells were seeded at 
low density in 24-well  culture plates in serum-containing 
medium to allow continued growth, and B subunit subse- 
quently added in the absence of serum after different times. 
In this latter case inhibition was also observed, irrespective 
of whether the cells were still actively dividing or had ceased 
to show further increases in number (Skaper, S. D., L. Facci, 
and M. Favaron, unpublished observations). The suggestion 
that the opposing responses of 313 fibroblasts to B subunit 
may be related to the amount or distribution of surface GM1 
being occupied (41) is based upon the observations that trans- 
formed 313 cells have less GM1 than normal 313 cells (16, 
20), and that the levels of cell surface gangliosides increase 
as normal 313 cells reach confluency (20).  The failure of as- 
troglial cells to display similar opposing growth responses to 
the B subunit may result for a variety of reasons. For exam- 
ple, astroglial cells may possess differences in their mem- 
brane ganglioside composition in comparison with normal 
313 cells. Treatment of the former cells with neuraminidase 
to convert polysialogangliosides to GM1 produces a several- 
fold increase in membrane GM1  content, as measured by 
binding  of a  B  subunit-horseradish  peroxidase  complex 
using ELISA (Favaron, M., S. D. Skaper, and L. Facci, un- 
published observations).  The inhibitory response of DNA 
synthesis to B subunit, however, remains after neuroamini- 
dase treatment. Differences between astroglia and 313 cells 
may also result from variations in the metabolic state of the 
two cell types when used or different mechanisms whereby 
B subunit acts. 
The mechanism(s) by which the B subunit is able to regulate 
the morphology and growth of astroglial cells is unknown. 
Interaction of membrane proteins with specific ligands can 
alter biochemical events in some cells. For example, B lym- 
phocytes are activated by antibodies that cross-link mem- 
brane immunoglobulins. This cross-linking  leads to enhanced 
inositol phospholipid metabolism and rapid increases in di- 
acylglycerol (3), elevation of intracellular free calcium con- 
centration, and phosphorylation of proteins associated with 
the plasma membrane and cytoskeleton (21). The growth- 
stimulatory action of the B subunit for resting 313 cells is 
reported to be associated with a rise of intracellular calcium 
that depends upon external calcium and increased membrane 
potential, but no enhancement of phosphoinositide turnover 
(40).  It is also possible that gangliosides may modulate pro- 
tein phosphorylation (4, 18, 24, 47), which in turn can serve 
as a signal to modulate both the cytoskeleton  and cell growth. 
These parameters remain to be examined in the present sys- 
tem. Since, however, the only known action of the B subunit 
is to bind to GMI ganglioside on the cell surface, the ex- 
pected cross-linking and subsequent aggregation of GM1 by 
the multivalent B subunit appears to be relevant to elicit these 
cellular behaviors. 
It is tempting to speculate that the same series of events 
are involved in the B subunit-induced change in astroglial 
cell morphology and inhibition of proliferation. Preliminary 
observations suggest that both the morphological and bio- 
chemical responses to the B subunit are linked to cytoskeletal 
stability at the level  of the microtubules  (Skaper,  S.  D., 
M. Favaron, and L. Facci, unpublished observations). An 
ability of endogenous gangliosides to modulate cytoskeletal 
organization would need to be reconciled with the fact that 
these lipid components do not span the cell membrane. One 
explanation  for a  cytoskeletal connection of gangliosides 
might be found in the interaction of gangliosides with one or 
more  integral membrane proteins,  which in turn  interact 
with cytoskeletal proteins directly, i.e., a bridging membrane 
protein that binds in a cis fashion to GM1 at the outer cell 
surface and in a  trans fashion to a  cytoskeletal-organizing 
protein at the inner plasma membrane. Recent observations 
concerning cooperativity of GMl-dependent with protein- 
dependent adhesion and  neuritogenesis of neuroblastoma 
cells lend support to this idea (32). In addition, there are sev- 
eral  reports  of possible  association of gangliosides with 
transmembrane proteins and cytoskeletal elements, based on 
their resistance to mild detergent extraction (19, 35, 43) and 
on capping in lymphocytes (22). 
The possible relationship between the opposing effects of 
B subunit versus exogenous GM1 raises an important issue, 
as it may be relevant to the reported therapeutic effects of ex- 
ogenously administered GM1 in lesion models of  the nervous 
system. For example, one could speculate that, in vivo, ex- 
ogenously added GM1 competes with the endogenous, mem- 
brane-bound GM1 for some unidentified endogenous GM1- 
binding substance (an analogue of  B subunit). Morphometric 
analysis has shown that the stellation transformation induced 
in cultured astroglial cells by treatment with cAMP ana- 
logues resembles the reactive astroglial cells which charac- 
teristically form in the vicinity of stab wounds in the brain 
(13, 14). The mechanism underlying this reactive gliosis is 
still not known. Some balance between cell surface ganglio- 
side levels and these responses may exist. By binding cell 
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in one direction, and by adding exogenous gangliosides one 
may tip the balance in the opposite direction. The actual situ- 
ation may not be so straightforward, however, as the added 
ganglioside  could  also  undergo  membrane  incorporation, 
perhaps working against the effects of free ganglioside. This 
astroglial culture system may still provide a useful model for 
investigating a role for gangliosides in gliosis;  such studies 
are presently  in progress. 
Taken together, these and past (12, 23, 36, 37) observations 
demonstrate that both endogenously occurring plasma mem- 
brane gangliosides  and exogenously  supplied gangliosides 
can play a role in the morphological and biochemical differ- 
entiation of astroglial  cells  in vitro.  Thus,  these astroglial 
cell cultures may provide a model system in which one can 
study a role for gangliosides as membrane transducers of sig- 
nals for cytoskeletal-linked events. The differences in mem- 
brane  concentration  and  distribution  of gangliosides  may 
influence membrane fluidity, with such changes in mobility 
being  linked  to  cytoskeletal  proteins  either  physically  or 
chemically. 
Received for publication U August 1987, and in revised form t8 November 
1987. 
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